Treatment optimization of canine thyroid tumors using newly identified molecular targets and recombinant human thyroid stimulating hormone.

01 November 2019 → 31 October 2023
Regional and community funding: Special Research Fund
Research disciplines
  • Medical and health sciences
    • Cancer therapy
    • Nuclear imaging
Canine thyroid tumor molecular targets organoids radioactive iodine therapy recombinant human thyroid stimulating hormone radioprotection
Project description

In general, we want to optimize the treatment of canine thyroid tumors.
We explore recent identified molecular targets in thyroid tumors in human and veterinary medicine by studying organoids of canine thyroid tumors, followed by a clinical study.
We search the best protocol of recombinant human thyroid stimulating hormone that increases the uptake of radioactive iodine in canine thyroid tumors.